Publications by authors named "Mamiko Takeuchi"

Claim this Profile
A
Association of Metabolic-Associated Steatotic Liver Disease With Clinical Outcomes of Durvalumab and Tremelimumab in Advanced Hepatocellular Carcinoma Patients: A Multicenter Study.
Takeshi Hatanaka, Shigeo Shimose, Takanori Ito, Joji Tani, Tetsu Tomonari, Yasuto Takeuchi, Mamiko Takeuchi

Hepatol Res· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A novel approach to evaluate the therapeutic efficacy of durvalumab and tremelimumab combination therapy in hepatocellular carcinoma.
Tetsu Tomonari, Shigeo Shimose, Issei Saeki, Joji Tani, Yuichi Honma, Mamiko Takeuchi, Yasuto Takeuchi

Hepatol Res· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antitumor effects and immune-mediated adverse events of durvalumab plus tremelimumab treatment for unresectable hepatocellular carcinoma.
Takanori Ito, Shigeo Shimose, Joji Tani, Tetsu Tomonari, Issei Saeki, Yasuto Takeuchi, Mamiko Takeuchi

Hepatol Res· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Distribution of Fibrosis-4 index and vibration-controlled transient elastography-derived liver stiffness measurement for patients with metabolic dysfunction-associated steatotic liver disease in health check-up.
Yuji Ogawa, Wataru Tomeno, Yasushi Imamura, Masaru Baba, Takato Ueno, Mamiko Takeuchi

Hepatol Res· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Alpha-fetoprotein and des-gamma-carboxy prothrombin can predict the objective response of patients with hepatocellular carcinoma receiving durvalumab plus tremelimumab therapy.
Issei Saeki, Shigeo Shimose, Tetsu Tomonari, Takanori Ito, Joji Tani, Yasuto Takeuchi, Mamiko Takeuchi

PLoS One· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Initial clinical experience with durvalumab plus tremelimumab in patients with unresectable hepatocellular carcinoma in real‑world practice.
Shigeo Shimose, Issei Saeki, Tetsu Tomonari, Takanori Ito, Joji Tani, Yasuto Takeuchi, Mamiko Takeuchi

Oncol Lett· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[A case of ischemic colitis induced by hypereosinophilic syndrome].
Yuhei Ichikawa, Mamiko Takeuchi, Masahiko Yamada, Tsutomu Hosoi, Tatsuhiko Mabuchi

Nihon Shokakibyo Gakkai Zasshi· December 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis